Outcome of a universal newborn hearing-screening programme based on multiple transient-evoked otoacoustic emissions and clinical brainstem response audiometry

2011 ◽  
Vol 131 (7) ◽  
pp. 728-739 ◽  
Author(s):  
Erik Berninger ◽  
Birgitta Westling
Keyword(s):  
Otoacoustic Emissions ◽  
Screening Programme ◽  
Hearing Screening ◽  
Newborn Hearing Screening ◽  
Transient Evoked Otoacoustic Emissions ◽  
Universal Newborn Hearing Screening ◽  
Newborn Hearing ◽  
Brainstem Response

Comparing Newborn Hearing Test Batteries: TEOAE and A-ABR – Pilot Study

2017 ◽  
pp. 36-41
Author(s):  
Esra Dogru Huzmeli
Keyword(s):  
Hearing Loss ◽  
Otoacoustic Emissions ◽  
Screening Programme ◽  
Auditory Brainstem ◽  
Hearing Screening ◽  
Newborn Hearing Screening ◽  
Newborn Hearing ◽  
Keywords Hearing Loss ◽  
Brainstem Response ◽  
Hearing Test

The aim of the newborn hearing screening programme is early detection of hearing loss. Transient evoked otoacoustic emissions (TEOAE) and automised auditory brainstem response (A-ABR) are effective, objective and valuable test batteries for newborn hearing screening, and they should be used together. The purpose of this study is to determine which test battery is more accurate and can be used as the gold standard. A total of 933 newborn children were included in this study, of which 602 were girls and 331 boys. 622 of them were screened with TEOAE, while 311 with A-ABR. 31 of the newborn screened with A-ABR and 27 of those screened with TEOAE were referred in the hearing screening programme. The results showed that out of 933, 17 subjects had hearing loss. The hearing loss rate was 1.8%; 12 of the newborn screened with AABR and 5 of those screened with TEOAE had hearing loss. Keywords: Hearing loss, TEOAE, ABR, newborn hearing screening.

scholarly journals NEWBORNS HEARING SCREENING WITH OTOACOUSTIC EMISSIONS AND AUDITORY BRAINSTEM RESPONSE

2020 ◽  
Vol 1 (1) ◽  
pp. 1
Author(s):  
Kusumagani Hamam ◽  
Nyilo Purnami
Keyword(s):  
Auditory Brainstem Response ◽  
Otoacoustic Emissions ◽  
Screening Method ◽  
Auditory Brainstem ◽  
Hearing Screening ◽  
Newborn Hearing Screening ◽  
Universal Newborn Hearing Screening ◽  
Newborn Hearing ◽  
Brainstem Response ◽  
Two Stages

Hearing loss in newborns is a serious matter, if it is not quickly diagnosed and starts early intervention, a child will experience social, speech, language, cognitive, and academic impairments. There is a method of hearing screening in newborns, which is divided into two types, universal newborn hearing screening, and targeted newborn screening. Both of these methods use OAEs and ABR as objective examination tools. The hearing screening method varies in each country, this difference is based on the test equipment used, age, frequency, professionals involved in screening, referral procedures, funding, and coverage areas. Indonesia uses two stages of screening, while Italy, America, Nigeria, France, India, and Poland use two to five stages of screening. Hearing screening of newborns using OAEs and ABR has a sensitivity of 100% and specificity of 99,3%.

Practicality, Validity, and Cost-Efficiency of Universal Newborn Hearing Screening Using Transient Evoked Otoacoustic Emissions

1995 ◽  
Vol 17 (1) ◽  
pp. 9-14 ◽  
Author(s):  
Karl R. White ◽  
Thomas R. Behrens ◽  
Bonnie Strickland
Keyword(s):  
Hearing Loss ◽  
Otoacoustic Emissions ◽  
Screening Program ◽  
The United States ◽  
Hearing Screening ◽  
Newborn Hearing Screening ◽  
Transient Evoked Otoacoustic Emissions ◽  
Screening Programs ◽  
Universal Newborn Hearing Screening ◽  
Newborn Hearing

Although the importance of identifying significant hearing loss at an early age has long been recognized, it is generally acknowledged that newborn hearing screening programs in the United States have not been very successful. The problem has been that available techniques were impractical, too expensive, or invalid. This article summarizes the data regarding the use of transient evoked otoacoustic emissions (TEOAE) in a universal newborn hearing screening program and describes various facets of program implementation. It is concluded that available data provide clear evidence that TEOAE can be used to significantly reduce the average age of identification for hearing loss in the U.S.

scholarly journals Newborn Hearing Screening: Experience from a Tertiary level Hospital in Nepal

2021 ◽  
Vol 4 (1) ◽  
pp. 33-36
Author(s):  
Pankaj Ray ◽  
Siba Thakali ◽  
Session Prajapati
Keyword(s):  
Hearing Loss ◽  
Otoacoustic Emissions ◽  
Neonatal Intensive Care ◽  
Auditory Brainstem ◽  
Hearing Screening ◽  
Newborn Hearing Screening ◽  
Congenital Hearing Loss ◽  
Universal Newborn Hearing Screening ◽  
Newborn Hearing ◽  
Brainstem Response

Introduction Congenital hearing loss is one of the commonest causes of hearing impairment and deafness in childhood. Early diagnosis and intervention in time help a child to lead a better life with good language and communication skills. Known risk factors include cytomegalovirus infection and premature birth necessitating a stay in the neonatal intensive care unit. Universal newborn hearing screening has been implemented by many countries due to easy and non-invasive screening test and their ability to identify children who may need early intervention. Methods: All the newborns delivered between December 2018 to November 2020 were screened for congenital hearing loss. The average age at screening was more than 24 hours. Those who were referred in OAE (otoacoustic emissions testing) underwent ABR (auditory brainstem response) test and further workup as needed. Conclusions: The incidence of congenital hearing loss was 1.8 per 1000 live births. This finding is consistent with other previous research. UNHS will be cost-effective easy and feasible method for early detection of hearing loss in newborns. Pediatric health services organizations should prioritize universal newborn hearing screening as a part of the standard of care in birthing services.  

Congenital Rubella Syndrome Screening for Newborn in Yogyakarta, Indonesia

2017 ◽  
Vol 13 (01) ◽  
pp. 051-056
Author(s):  
Agung Triono ◽  
Oktania Candrawati ◽  
Kartono Sudarman ◽  
Umi Intansari ◽  
Ekawaty Haksari ◽  
...  
Keyword(s):  
Hearing Loss ◽  
Otoacoustic Emissions ◽  
Auditory Brainstem ◽  
Hearing Screening ◽  
Congenital Rubella Syndrome ◽  
Newborn Hearing Screening ◽  
Congenital Rubella ◽  
Universal Newborn Hearing Screening ◽  
Newborn Hearing ◽  
Brainstem Response

Background Rubella infection in pregnancy can cause congenital rubella syndrome (CRS), and one common defect of CRS is hearing loss. However, hearing screening is not routinely performed in Indonesia. While the number of reported cases of CRS in Indonesia is increasing, it is still difficult to identify all CRS cases. This study aims to identify CRS cases through a newborn hearing screening. Materials and Methods This descriptive study was conducted at Dr. Sardjito Hospital, Yogyakarta, Indonesia. The subjects were recruited from September 1, 2013 to November 19, 2013. The study period was from September 1, 2013 to January 31, 2014. Newborn subjects underwent the first otoacoustic emissions (OAEs) test. Subjects with the first OAEs test REFER results underwent the second OAEs test 2 months later. Subjects with REFER result in the second OAEs test then underwent auditory brainstem response (ABR) and detection of rubella IgM in blood serum. Result There were 151 subjects who underwent the first OAEs test. Ninety subjects (60%) had REFER results, but only 29 subjects underwent the second OAEs test. In the second OAEs test, 9/151 (5%) subjects were REFER. There were 6/151 (3.9%) subjects who underwent ABR and all subjects had sensory neural hearing loss. Of them, one subject was positive for rubella IgM with a titer of 11.86 at 2.5 months of age. We found nine suspected CRS cases, one clinically-confirmed and one laboratory-confirmed CRS case. The incidence of laboratory-confirmed CRS was 1/151 (6.62/1,000) live births. Conclusion Due to the low incidence we found and the cost of screening, we recommend to strengthen surveillance of CRS. All infants less than 1 year of age with suspected CRS should be checked with rubella IgM to identify CRS cases. While universal newborn hearing screening is not mandatory in Indonesia, targeted newborn hearing screening should be performed to detect children with permanent congenital hearing loss due to CRS.

scholarly journals Newborn Hearing Screening in Bavaria—Is It Possible to Reach the Quality Parameters?

2018 ◽  
Vol 4 (3) ◽  
pp. 26
Author(s):  
Inken Brockow ◽  
Kristina Söhl ◽  
Uta Nennstiel
Keyword(s):  
Screening Test ◽  
Otoacoustic Emissions ◽  
Tracking System ◽  
Quality Criteria ◽  
Hearing Screening ◽  
Screening Methods ◽  
Newborn Hearing Screening ◽  
Automated Auditory Brainstem Response ◽  
Newborn Hearing ◽  
Brainstem Response

Since the 1 January, 2009, newborn hearing screening (NHS) has been obligatory for every child in Germany. NHS is part of the Pediatrics Directive of the Federal Joint Committee. In this directive, details of the procedures and screening quality to be achieved are given. We evaluate if these quality criteria were met in Bavaria in 2016. The NHS data of children born in 2016 in Bavaria were evaluated for quality criteria, such as screening coverage in screening facilities, screening methods, referral rate (rate of failed tests at discharge) and a child’s age at the diagnosis of a hearing disorder. NHS was documented for 116,776 children born in Bavaria in 2016. In the first step, 78,904 newborns were screened with transient evoked otoacoustic emissions and 37,865 with automated auditory brainstem response. Of these, 9182 (7.8%) failed the first test in one or both ears. A second screening before discharge was performed on 53.3% of the newborns with a refer result in the first test, out of which 58.7% received a pass result. After the screening process, 4.6% of the newborns were discharged with a refer result. Only 18% of the first controls after discharge were performed by a pediatric audiologist. In 37.9% of the newborns, the screening center intervened to assure the control of any failed screening test. The median age of diagnosis for bilateral hearing loss was 5.3 months. In Bavaria, NHS was implemented successfully. A tracking system for all children who failed the hearing screening test is pivotal for early diagnosis and therapy of children with hearing deficiency.

scholarly journals First national results of the evaluation of the neonatal hearing loss screening programme in France

2019 ◽  
Vol 29 (Supplement_4) ◽  
Author(s):  
A Doncarli ◽  
H Tillaut ◽  
V Goulet
Keyword(s):  
Hearing Loss ◽  
Screening Programme ◽  
National Level ◽  
Hearing Screening ◽  
Newborn Hearing Screening ◽  
Universal Newborn Hearing Screening ◽  
Newborn Hearing ◽  
Set Up ◽  
Bilateral Deafness

Abstract Background The French newborn hearing screening programme set up in 2014 aims to identify affected children as early as possible to allow appropriate care. Our goal was to evaluate the implementation of this programme at the national level. Methods The programme consist in a screening using a test (T1) and a retest (T2) in the maternity hospital in all newborns. In some region, a delayed test (T3) is performed afterwards in children for whom it was not possible to confirm normal hearing. Children suspected of deafness subsequently enter the diagnosis phase. We defined evaluation indicators after stakeholders consultation. We developed a web application to collect aggregated data on live births. We estimated the rate of coverage, refusal, children suspected of hearing loss at the end of the screening phase and the prevalence of bilateral deafness. Results In 2015, one year after the initiation of the programme, the coverage rate was already very high (88%) and even more so in 2016 (96%). Parental acceptance was very good (refusal: 0.1%). By the end of 2016, 19 out 27 regions had added a T3. The rate of suspicion of bilateral hearing loss was decreased by using a T3 (1.4% vs 0.9%). Bilateral deafness rate, estimated after a 2-years follow up, was 1.3‰ although it was estimated only on 51.5% of suspected children for whom diagnosis data had been transmitted. Conclusions The objective of a 90% coverage set by the French ministry of health has been met after 2 years of operation of the program. T3 appears useful in relieving diagnostic structures from false positives. Our estimated prevalence of bilateral deafness could be more accurate if data collection was improved but is consistent with prevalence reported in North America. Key messages The universal newborn hearing screening program has been successfully set up in France in terms of coverage. Future work should focus on improving the collection of follow up data to better characterise diagnosed children.

Sign in / Sign up

Export Citation Format

Share Document